Anika Therapeutics ANIK
NASDAQ ANIK
$19.10 -0.26 (-1.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Anika Therapeutics (ANIK) Return on Sales [ROS] (2010 - 2026)

Updated

Anika Therapeutics (ANIK) recorded Return on Sales [ROS] of 9.06% in Q2 2026, up 23.87 percentage points from -14.81% a year earlier and up 27.59 percentage points from the prior quarter.

Analysis

Anika Therapeutics (ANIK) Return on Sales [ROS] (2010 - 2026) Analysis & Trends

On a TTM basis, Anika Therapeutics' Return on Sales [ROS] came in at -4.24% as of Jun 30, 2026, up 3.83 percentage points year-over-year; for FY2025, it was -9.80%, down 5.54 percentage points from FY2024.

  • Annual Return on Sales [ROS] has declined for three straight years, though with a five-year change of +11.91 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Sales [ROS] came in at -4.25% in FY2024 (-4.95 pp), 0.70% in FY2023 (-2.53 pp), 3.22% in FY2022 (+1.45 pp) and 1.77% in FY2021 (+23.48 pp).
  • The Q2 2026 figure is the highest quarterly Return on Sales [ROS] since Q2 2021.
  • On a year-over-year basis, Return on Sales [ROS] rose in three of the last eight quarters, with an average year-over-year change of +1.67 percentage points.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 29.45 percentage points in Q4 2021, against a drop of 32.59 percentage points in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -18.53% (Q1 2026), 2.11% (Q4 2025) and -11.62% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 13.44%
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 33.60%
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 18.08%
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 25.18%
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 21.65%
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 29.48%
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 13.31%
10 Anika Therapeutics 255.62 Mn -10.93 Mn 21.24 Mn 9.06%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.06%
Mar 31, 2026 -18.53%
Dec 31, 2025 2.11%
Sep 30, 2025 -11.62%
Jun 30, 2025 -14.81%
Mar 31, 2025 -16.37%
Dec 31, 2024 -2.30%
Sep 30, 2024 -0.27%
Jun 30, 2024 -5.89%
Mar 31, 2024 -8.63%
Dec 31, 2023 0.70%
Sep 30, 2023 -18.51%
Jun 30, 2023 -8.20%
Mar 31, 2023 -33.10%
Dec 31, 2022 3.22%
Sep 30, 2022 -14.40%
Jun 30, 2022 -8.53%
Mar 31, 2022 -9.69%
Dec 31, 2021 -25.47%
Sep 30, 2021 3.29%
API Access

Anika Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ANIK&period=max&api_key=YOUR_API_KEY